DMD and Duchenne muscular dystrophy: More recently, systemic treatment of DMD patients with PMO was reported to induce detectable amount of dystrophin protein in sampled skeletal muscles of all patients, although considerable variation in skipping efficiency was also clearly observed within the trial population.